Stroke News

Implantable loop recorder screening for atrial fibrillation did not significantly reduce the risk for stroke compared with usual care, according to study results published in JAMA Neurology.

The European Society of Cardiology task force on cardio-oncology has issued its inaugural guideline for the prevention and management of cardiotoxicity before, during and after adult patients are treated with anticancer therapies.

Poor physical function was associated with increased risk for CHD, stroke and HF in adults older than 65 years, according to a new analysis of the Atherosclerosis Risk in Communities study.

In the U.S., the use of carotid artery stenting has never been as widespread as that of carotid endarterectomy, which is partly a function of the CMS coverage decision. That may be about to change.

In the AXIOMATIC-SSP trial, milvexian, a novel factor XIa inhibitor, was protective against ischemic stroke with no increased risk for intracranial hemorrhage compared with placebo in patients requiring secondary prevention.

In patients with rheumatic heart disease-associated atrial fibrillation, vitamin K antagonist therapy was associated with a lower rate of ischemic stroke and mortality compared with rivaroxaban, without increasing risk for major bleeding.

Supraventricular arrhythmias may be underestimated in patients who have received percutaneous patent foramen ovale closure for stroke prevention, researchers reported at the European Society of Cardiology Congress.

More adults with type 2 diabetes achieved guideline-recommended strategies for stroke prevention in 2018 compared with 2001, but further improvements are needed, according to study findings published in Diabetes Care.

A database analysis showed no association between messenger RNA COVID-19 vaccines and risk for acute MI, stroke or pulmonary embolism, but a slight increase in risk for PE and MI after receiving the AstraZeneca or Janssen vaccines.

Among patients with clinical hypertension, researchers observed greater risk for CV events among men with high and low HDL levels compared with men with medium HDL, defined as 40 mg/dL to 80 mg/dL.